Inovio Pharma (INO) Reports Complete Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for Treatment of HPV-Related Cervical Pre-cancer - StreetInsider.com

Inovio Pharma (INO) Reports Complete Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for Treatment of HPV-Related Cervical Pre-cancer  StreetInsider.com

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.